Impact Biomedical, Stock Probability of Future Stock Price Finishing Over 36.75
| IBO Stock | USD 1.80 0.05 2.70% |
Impact |
Impact BioMedical, Target Price Odds to finish over 36.75
The tendency of Impact Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 36.75 or more in 90 days |
| 1.80 | 90 days | 36.75 | close to zero percent |
Based on a normal probability distribution, the odds of Impact BioMedical, to move over $ 36.75 or more in 90 days from now is close to zero percent (This Impact BioMedical, probability density function shows the probability of Impact Stock to fall within a particular range of prices over 90 days) . Probability of Impact BioMedical, price to stay between its current price of $ 1.80 and $ 36.75 at the end of the 90-day period is about 68.18 .
Considering the 90-day investment horizon the stock has the beta coefficient of 2.52 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Impact BioMedical, will likely underperform. Additionally Impact BioMedical, has an alpha of 0.8581, implying that it can generate a 0.86 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Impact BioMedical, Price Density |
| Price |
Predictive Modules for Impact BioMedical,
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Impact BioMedical,. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Impact BioMedical, Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Impact BioMedical, is not an exception. The market had few large corrections towards the Impact BioMedical,'s value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Impact BioMedical,, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Impact BioMedical, within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.86 | |
β | Beta against Dow Jones | 2.52 | |
σ | Overall volatility | 0.55 | |
Ir | Information ratio | 0.07 |
Impact BioMedical, Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Impact BioMedical, for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Impact BioMedical, can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Impact BioMedical, is way too risky over 90 days horizon | |
| Impact BioMedical, may become a speculative penny stock | |
| Impact BioMedical, appears to be risky and price may revert if volatility continues | |
| Impact BioMedical, has high likelihood to experience some financial distress in the next 2 years | |
| Reported Net Loss for the year was (4.34 M) with profit before taxes, overhead, and interest of 0. | |
| Impact BioMedical, generates negative cash flow from operations | |
| Impact BioMedical, has a frail financial position based on the latest SEC disclosures | |
| About 55.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Discretionary transaction by Dss, Inc. of tradable shares of Impact BioMedical, subject to Rule 16b-3 |
Impact BioMedical, Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Impact Stock often depends not only on the future outlook of the current and potential Impact BioMedical,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Impact BioMedical,'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 11.5 M |
Impact BioMedical, Technical Analysis
Impact BioMedical,'s future price can be derived by breaking down and analyzing its technical indicators over time. Impact Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Impact BioMedical,. In general, you should focus on analyzing Impact Stock price patterns and their correlations with different microeconomic environments and drivers.
Impact BioMedical, Predictive Forecast Models
Impact BioMedical,'s time-series forecasting models is one of many Impact BioMedical,'s stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Impact BioMedical,'s historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Impact BioMedical,
Checking the ongoing alerts about Impact BioMedical, for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Impact BioMedical, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Impact BioMedical, is way too risky over 90 days horizon | |
| Impact BioMedical, may become a speculative penny stock | |
| Impact BioMedical, appears to be risky and price may revert if volatility continues | |
| Impact BioMedical, has high likelihood to experience some financial distress in the next 2 years | |
| Reported Net Loss for the year was (4.34 M) with profit before taxes, overhead, and interest of 0. | |
| Impact BioMedical, generates negative cash flow from operations | |
| Impact BioMedical, has a frail financial position based on the latest SEC disclosures | |
| About 55.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Discretionary transaction by Dss, Inc. of tradable shares of Impact BioMedical, subject to Rule 16b-3 |
Check out Impact BioMedical, Backtesting, Impact BioMedical, Valuation, Impact BioMedical, Correlation, Impact BioMedical, Hype Analysis, Impact BioMedical, Volatility, Impact BioMedical, History as well as Impact BioMedical, Performance. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical, guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Impact BioMedical,. If investors know Impact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Impact BioMedical, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Impact BioMedical, is measured differently than its book value, which is the value of Impact that is recorded on the company's balance sheet. Investors also form their own opinion of Impact BioMedical,'s value that differs from its market value or its book value, called intrinsic value, which is Impact BioMedical,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Impact BioMedical,'s market value can be influenced by many factors that don't directly affect Impact BioMedical,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Impact BioMedical,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Impact BioMedical, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Impact BioMedical,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.